SS

Sheryl Shama Salis

Active Director Director DIN 11031175
DIN 11031175 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sheryl Shama Salis

Data last updated:

Sheryl Shama Salis is a Director at Kasturba Integrative Health Sciences - Medical Research Foundation (since 2025).

DIN 11031175
Primary Designation Director
First Appointment 01 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Apr 20252025Active

Directorship timeline

Open interactive timeline →
Kasturba Integrative Health Sciences - Medical Research Foundation
Premium access

Shareholding and investment profile for Sheryl Shama Salis

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sheryl Shama Salis

Sheryl Shama Salis currently holds 1 directorship: Kasturba Integrative Health Sciences - Medical Research Foundation (Director, since 01 Apr 2025).

Sheryl Shama Salis was first appointed on 01 Apr 2025 as Director at Kasturba Integrative Health Sciences - Medical Research Foundation.

The current boards of Sheryl Shama Salis's companies include Rama Ashok Vaidya (Kasturba Integrative Health Sciences - Medical Research Foundation), Shobha Anand Udipi (Kasturba Integrative Health Sciences - Medical Research Foundation), Soumik Prakash Kalita (Kasturba Integrative Health Sciences - Medical Research Foundation).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available